Lilly's Mounjaro® (tirzepatide) Approved in Hong Kong in KwikPen® Presentation for Chronic Weight Management and Type 2 Diabetes, Offering a New Option for the Treatment of Obesity, Overweight and Type 2 Diabetes

Adults taking Mounjaro in a clinical trial lost on average 48 lb. at the highest dose1,2 Mounjaro delivered superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials6-12

BRICS Leaders Call for Urgent Action on Land Degradation Ahead of UN Land Degradation and Drought COP in Riyadh

Saudi Arabia welcomes intervention on critical environmental issue ahead of UNCCD COP16 RIYADH,Saudi Arabia,Oct. 28,2024--BRICS leaders have issued a joint statement calling for increased financial re

Ping An Health Collaborates with Industry to Launch China's First "Internet-Based Family Doctor Service Standards"

HONG KONG and SHANGHAI,Oct. 28,2024-- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor","Ping An Health",or "the Company",Stock Code: 1833.HK)recent

RemeGen Announces the Acceptance of the Marketing Application of Telitaccept for the Treatment of Myasthenia Gravis in China

YANTAI,China,Oct. 29,2024-- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK,688331.SH),a commercial-stage biotechnology company,recently announced that the marketing applic

State Grid Ningdong Power Supply Company: Successful Completion and Operation of Yunhai 330 kV Substation